UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Coinfection of Hepatitis C Virus with Human Immunodeficiency Virus and Progression to AIDS

The Journal of infectious diseases, 1995-12, Vol.172 (6), p.1503-1508

1995

Volltextzugriff (PDF)

Production of β-Chemokines in Human Immunodeficiency Virus (HIV) Infection: Evidence that High Levels of Macrophage Inflammatory Protein-1β Are Associated with a Decreased Risk of HIV Disease Progression

The Journal of infectious diseases, 1998-02, Vol.177 (2), p.331-336

1998

Volltextzugriff (PDF)

CD4 Lymphocyte Count as a Predictor of the Duration of Highly Active Antiretroviral Therapy—Induced Suppression of Human Immunodeficiency Virus Load

The Journal of infectious diseases, 1999-08, Vol.180 (2), p.530-533

1999

Volltextzugriff (PDF)

The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection

AIDS (London), 1998-09, Vol.12 (13), p.1639-1643

1998

Volltextzugriff (PDF)

The spectrum of AIDS-defining diseases : temporal trends in italy prior to the use of highly active anti-retroviral therapies, 1982-1996

International journal of epidemiology, 1999-10, Vol.28 (5), p.975-981

1999

Volltextzugriff (PDF)

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients

AIDS (London), 2000-03, Vol.14 (5), p.499-507

2000

Volltextzugriff (PDF)

Natural immunity and HIV disease progression

AIDS (London), 1999-04, Vol.13 (5), p.557-563

1999

Volltextzugriff (PDF)

Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection

Blood, 2000-12, Vol.96 (13), p.4091-4095

2000

Volltextzugriff (PDF)

Community-Acquired Pneumonia in a Cohort of Former Injection Drug Users With and Without Human Immunodeficiency Virus Infection: Incidence, Etiologies, and Clinical Aspects

Clinical infectious diseases, 1996-07, Vol.23 (1), p.107-113

1996

Volltextzugriff (PDF)

Reasons for modification and discontinuation of antiretrovirals : results from a single treatment centre

AIDS (London), 2001-01, Vol.15 (2), p.185-194

2001

Volltextzugriff (PDF)

Risk of new AIDS diseases in people on triple therapy

The Lancet (British edition), 1999-02, Vol.353 (9151), p.463-463

1999

Volltextzugriff (PDF)

Increased losses of CD4+CD45RA+ cells in late stages of HIV infection is related to increased risk of death : evidence from a cohort of 347 HIV-infected individuals

AIDS (London), 1997-10, Vol.11 (12), p.1479-1485

1997

Volltextzugriff (PDF)

Is the CD4 Cell Percentage a Better Marker of Immunosuppression than the Absolute CD4 Cell Count in HIV-Infected Patients with Cirrhosis?

Clinical infectious diseases, 2007-09, Vol.45 (5), p.650-653

2007

Volltextzugriff (PDF)

The influence of nutritional and metabolic status on progression from asymptomatic HIV infection to AIDS-defining diagnosis

AIDS (London), 1999-07, Vol.13 (10), p.1221-1226

1999

Volltextzugriff (PDF)

Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study

Journal of acquired immune deficiency syndromes (1999), 2006-01, Vol.41 (1), p.23-30

2006

Volltextzugriff (PDF)

When to start highly active antiretroviral therapy in chronically HIV-infected patients : evidence from the ICONA study

AIDS (London), 2001-05, Vol.15 (8), p.983-990

2001

Volltextzugriff (PDF)

Risk Factors for HTLV-I and II in Individuals Attending a Clinic for Sexually Transmitted Diseases

Sexually transmitted diseases, 2000-02, Vol.27 (2), p.87-92

2000

Volltextzugriff (PDF)

Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individuals

AIDS (London), 2001-12, Vol.15 (18), p.2379-2384

2001

Volltextzugriff (PDF)

The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4-8 viral load

AIDS (London), 2001-01, Vol.15 (1), p.47-54

2001

Volltextzugriff (PDF)

Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. Study

Journal of acquired immune deficiency syndromes (1999), 2003-10, Vol.34 (2), p.184-190

2003

Volltextzugriff (PDF)

Temporal Trends of Initial CD4 Cell Counts Following Human Immunodeficiency Virus Seroconversion in Italy, 1985–1992

American journal of epidemiology, 1996-02, Vol.143 (3), p.278-282

1996

Volltextzugriff (PDF)

The rate of CD4 decline as a determinant of progression to AIDS independent of the most recent CD4 count

Epidemiology and infection, 1998-10, Vol.121 (2), p.369-376

1998

Volltextzugriff (PDF)

Resistance Profiles in Patients with Viral Rebound on Potent Antiretroviral Therapy

The Journal of infectious diseases, 2000-03, Vol.181 (3), p.1143-1147

2000

Volltextzugriff (PDF)

Definition of loss of virological response in trials of antiretroviral drugs

AIDS (London), 2003-09, Vol.17 (13), p.1997-1998

2003

Volltextzugriff (PDF)

The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997

AIDS (London), 1999-07, Vol.13 (10), p.1255-1261

1999

Volltextzugriff (PDF)

1 – 25 von 505

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(458)
Mit Volltextzugriff
(388)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Coinfection of Hepatitis C Virus with Human Immunodeficiency Virus and Progression to AIDS

Production of β-Chemokines in Human Immunodeficiency Virus (HIV) Infection: Evidence that High Levels of Macrophage Inflammatory Protein-1β Are Associated with a Decreased Risk of HIV Disease Progression

CD4 Lymphocyte Count as a Predictor of the Duration of Highly Active Antiretroviral Therapy—Induced Suppression of Human Immunodeficiency Virus Load

The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection

The spectrum of AIDS-defining diseases : temporal trends in italy prior to the use of highly active anti-retroviral therapies, 1982-1996

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients

Natural immunity and HIV disease progression

Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection

Community-Acquired Pneumonia in a Cohort of Former Injection Drug Users With and Without Human Immunodeficiency Virus Infection: Incidence, Etiologies, and Clinical Aspects

Reasons for modification and discontinuation of antiretrovirals : results from a single treatment centre

Risk of new AIDS diseases in people on triple therapy

Increased losses of CD4+CD45RA+ cells in late stages of HIV infection is related to increased risk of death : evidence from a cohort of 347 HIV-infected individuals

Is the CD4 Cell Percentage a Better Marker of Immunosuppression than the Absolute CD4 Cell Count in HIV-Infected Patients with Cirrhosis?

The influence of nutritional and metabolic status on progression from asymptomatic HIV infection to AIDS-defining diagnosis

Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study

When to start highly active antiretroviral therapy in chronically HIV-infected patients : evidence from the ICONA study

Risk Factors for HTLV-I and II in Individuals Attending a Clinic for Sexually Transmitted Diseases

Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individuals

The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4-8 viral load

Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. Study

Temporal Trends of Initial CD4 Cell Counts Following Human Immunodeficiency Virus Seroconversion in Italy, 1985–1992

The rate of CD4 decline as a determinant of progression to AIDS independent of the most recent CD4 count

Resistance Profiles in Patients with Viral Rebound on Potent Antiretroviral Therapy

Definition of loss of virological response in trials of antiretroviral drugs

The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997

Suchergebnisse filtern